DNAM-1, as a member of the Ig superfamily, participates in tumor recognition and activation by recognizing its ligand CD155, is relevant to many adverse autoimmune diseases, and may serve as a target for the treatment of diseases [30,31,32]. The gene discussed is PVR; the disease is autoimmune disease.